ACTRN12612001257853CompletedPhase 2
Red light (670nm) treatment to prevent retinopathy of prematurity (ROP)
Canberra Hospital0 sites25 target enrollmentStarted: November 29, 2012Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Enrollment
- 25
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Non-randomised trial
- Primary Purpose
- Prevention
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- 24 Weeks to 30 Weeks (—)
- Sex
- All
Inclusion Criteria
- •Premature neonates less than 30 weeks gestation or less than 1150 grams birthweight
- •Informed consent obtained in the first 24-48 hours of life
Exclusion Criteria
- •Significant chromosomal or congenital anomalies
Investigators
Similar Trials
Unknown
Not Applicable
Red Light Intervention on Myopic ProgressionMyopiaNCT05203432Shanghai Eye Disease Prevention and Treatment Center104
Completed
Not Applicable
Red Light Intervention for Myopia PreventionMyopiaNCT04825769Shanghai Eye Disease Prevention and Treatment Center278
Not yet recruiting
Not Applicable
Retinal laser photocoagulation to ameliorate choroidal congestion in central serous chorioretinopathyCentral serous chorioretinopathyJPRN-UMIN000041454Gunma university hospital20
Recruiting
Not Applicable
Efficacy of Repeated Low-level Red-light Therapy in Myopia ControlMyopiaNCT05606237University of California, San Francisco90
Completed
Phase 2
Light Emitting Diode (LED) for the Treatment of WrinklesSkin AgingPhotoaging of SkinNCT00818246RoseLab Skin Optics Laboratory40